New combo may ease chemo nausea for breast cancer patients
NCT ID NCT03367572
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 18 times
Summary
This study looked at whether adding prochlorperazine or olanzapine to standard anti-nausea medication can better control nausea and vomiting caused by chemotherapy in breast cancer patients. Over 1,300 women starting chemotherapy took part. The goal was to find a more effective way to manage these common and distressing side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aurora NCORP
Milwaukee, Wisconsin, 53226, United States
-
Cancer Research Consortium of West Michigan
Grand Rapids, Michigan, 49503, United States
-
Cancer Research for the Ozarks NCORP
Springfield, Missouri, 65804, United States
-
Columbus NCORP
Columbus, Ohio, 43215, United States
-
Dayton Clinical Oncology Program
Dayton, Ohio, 45459, United States
-
Decatur Memorial Hospital
Decatur, Illinois, 62526, United States
-
Geisinger Cancer Institute NCORP
Danville, Pennsylvania, 17822, United States
-
Greenville NCORP
Greenville, South Carolina, 29615, United States
-
Gulf South MU-NCORP
New Orleans, Louisiana, 70112, United States
-
Gundersen Health System
La Crosse, Wisconsin, 54601, United States
-
Hawaii MU NCORP
Honolulu, Hawaii, 96813, United States
-
Health Partners Inc
Minneapolis, Minnesota, 55454, United States
-
Michigan Cancer Research Consortium
Ann Arbor, Michigan, 48106, United States
-
Nevada Cancer Research Foundation NCORP
Las Vegas, Nevada, 89106, United States
-
Saint Vincent Hospital Cancer Center Green Bay
Green Bay, Wisconsin, 54301, United States
-
Southeast Clinical Oncology Research Program
Winston-Salem, North Carolina, 27104, United States
-
University of Rochester NCORP Research Base
Rochester, New York, 14642, United States
-
Upstate Carolina NCORP
Spartanburg, South Carolina, 29303, United States
Conditions
Explore the condition pages connected to this study.